Key Takeaways
- • GTCR has agreed to sell Corza Medical's Biosurgery business, including the TachoSil product portfolio, to EQT following a six-year hold period since the company's formation.
- • Lone Star Partners has agreed to acquire ContiTech for approximately €4 billion, representing a significant infrastructure investment in the automotive supplier sector.
- • Both transactions represent continued M&A activity in the healthcare and industrial sectors, with established sponsors executing exit strategies and deploying capital into complementary assets.
Summary
GTCR has completed a definitive agreement to divest the Biosurgery division of Corza Medical to EQT, marking an exit from the portfolio company approximately six years after its inception. The transaction includes the TachoSil product portfolio, a key revenue driver within the Biosurgery segment. While specific deal valuation was not disclosed in available sources, the sale reflects GTCR's investment thesis maturation and strategic repositioning of its healthcare holdings.
In parallel, Lone Star Partners has committed to acquiring ContiTech, a major automotive components and industrial supplier, for €4 billion. This transaction underscores continued institutional capital deployment toward established industrial platforms with recurring revenue characteristics and market positioning.
Both deals illustrate the ongoing exit velocity within the middle-market and lower-middle-market private equity ecosystem, where sponsors are capitalizing on favorable market conditions and strategic buyer demand. The Corza Biosurgery transaction to EQT, a prominent European growth equity and buyout investor, suggests sector consolidation and cross-sponsor portfolio optimization. The ContiTech acquisition by Lone Star reflects infrastructure-focused capital seeking exposure to automotive supply chain resilience and operational improvement opportunities in industrials.
In parallel, Lone Star Partners has committed to acquiring ContiTech, a major automotive components and industrial supplier, for €4 billion. This transaction underscores continued institutional capital deployment toward established industrial platforms with recurring revenue characteristics and market positioning.
Both deals illustrate the ongoing exit velocity within the middle-market and lower-middle-market private equity ecosystem, where sponsors are capitalizing on favorable market conditions and strategic buyer demand. The Corza Biosurgery transaction to EQT, a prominent European growth equity and buyout investor, suggests sector consolidation and cross-sponsor portfolio optimization. The ContiTech acquisition by Lone Star reflects infrastructure-focused capital seeking exposure to automotive supply chain resilience and operational improvement opportunities in industrials.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.